This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Progressive Medical Launches Comprehensive Urine Drug Monitoring Network

WESTERVILLE, Ohio, April 9, 2013 /PRNewswire/ -- Reinforcing its belief that urine drug monitoring (UDM) is an important component of an overall medication compliance and opioid management program, Progressive Medical announces a comprehensive UDM network that includes a select group of the nation's top clinical diagnostic companies.

As a pharmacy benefit manager for the workers' compensation industry, Progressive Medical has employed UDM in its pain management program for a number of years. The formal network of preferred providers makes it easy for clients to gain even greater insight into prescription medication use and helps to identify potential fraud and abuse while at the same time manage the costs of screenings.

Network members were hand selected based on a number of factors such as national coverage, expertise with workers' compensation claims and credentials, including Clinical Laboratory Improvement Amendments (CLIA) certification and College of American Pathologists (CAP) accreditation.

While the network provides access to world-class testing facilities, Progressive Medical delivers a network solution that brings consistency and predictability to the forefront and supports a centralized reporting process across providers, ensuring a streamlined experience for clients. Another key advantage is the company's ability to identify claimants who may benefit from drug monitoring and if warranted, integrate them into the most appropriate clinical intervention program to achieve the best possible outcome.

"We not only built a comprehensive program that provides for reporting consistency and cost containment, it's also highly customizable from a client perspective," said Dan Gifford, executive vice president for product development. "We consult with clients to establish the identification criteria and create an action plan for follow up and retesting based on their needs and internal guidelines. And our program enables clients and physicians to choose which network providers they use, since they can expect a consistent process and centralized reporting of the results."

While drug testing may traditionally be viewed as an effort to "catch" misuse or abuse, Progressive Medical sees it as an invaluable tool in confirming injured workers are taking their medications, from both a safety and a cost standpoint.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,079.31 +55.25 0.31%
S&P 500 2,113.73 +5.44 0.26%
NASDAQ 5,016.1880 +10.7970 0.22%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs